This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (6)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Dermatologic Disorders  • Dermatologic Disorders, Other  • Genetics  • Genetic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

David R. Berk, MD; Elaine B. Spector, PhD; Susan J. Bayliss, MD

Arch Dermatol. 2007;143(9):1153-1156.

Background  Acanthosis nigricans is a feature of several syndromes caused by activating mutations of the fibroblast growth factor receptor 3 gene (FGFR3), including Crouzon syndrome with acanthosis nigricans, thanatophoric dysplasia, and severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN syndrome).

Observations  We describe a healthy 4-year-old African American girl with generalized acanthosis nigricans since infancy. Her father had a history of acanthosis nigricans since childhood, in addition to Crohn disease, obesity, and adult-onset diabetes mellitus. A pedigree with numerous affected family members was constructed. Other than slightly short stature, no associated anomalies were found, including dysmorphic features or skeletal or neurologic defects. Genetic testing revealed a previously undescribed, heterozygous lysine to threonine mutation at codon 650 of the FGFR3 gene in the 4 affected family members who were tested.

Conclusion  Extensive acanthosis nigricans in early childhood, especially with a family history of acanthosis nigricans, may warrant testing for FGFR3 mutations.

Author Affiliations: Department of Internal Medicine, Division of Dermatology, and Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri (Drs Berk and Bayliss); and DNA Diagnostic Laboratory and Department of Pediatrics, University of Colorado at Denver and Health and Sciences Center, Aurora (Dr Spector).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Clinical, Biochemical, and Genetic Study of 11 Patients With Erythropoietic Protoporphyria Including One With Homozygous Disease
Carmen Herrero, Jordi To-Figueras, Celia Badenas, Manuel Méndez, Patricia Serrano, Rafael Enríquez-Salamanca, and Mario Lecha
Arch Dermatol. 2007;143(9):1125-1129.
ABSTRACT | FULL TEXT  

Dermatology and the Human Genome: An Epidemiologic Approach
Marta Gwinn and Muin J. Khoury
Arch Dermatol. 2007;143(9):1194-1196.
EXTRACT | FULL TEXT  

A Novel Missense Mutation in the CYLD Gene in a Spanish Family With Multiple Familial Trichoepithelioma
Agustín España, Fermin García-Amigot, Leyre Aguado, and Jesús García-Foncillas
Arch Dermatol. 2007;143(9):1209-1210.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Acanthosis Nigricans and Insulin Sensitivity in Patients with Achondroplasia and Hypochodroplasia due to FGFR3 Mutations
Alatzoglou et al.
J. Clin. Endocrinol. Metab. 2009;94:3959-3963.
ABSTRACT | FULL TEXT  

Type 2 Segmental Acanthosis Nigricans: A Historical Case Explained by a New Concept
Happle
Arch Dermatol 2008;144:1637-1637.
FULL TEXT  

Hypochondroplasia and acanthosis nigricans: a new syndrome due to the p.Lys650Thr mutation in the fibroblast growth factor receptor 3 gene?
Castro-Feijoo et al.
Eur J Endocrinol 2008;159:243-249.
ABSTRACT | FULL TEXT  

Dermatology and the Human Genome: An Epidemiologic Approach
Gwinn and Khoury
Arch Dermatol 2007;143:1194-1196.
FULL TEXT